Biocair to participate in cell and gene webinar to explore ongoing material sourcing challenges

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Merck to Acquire Verona for $10B, COPD Drug in Focus

Merck has pulled off another acquisition that happens to...

PDUFA Crucial for Biopharmaceutical Innovation in the US

The United States happens to lead the world when...

The Evolution of Self-Care: Where Vitauthority Fits in the Wellness Era

Over the past few decades, the concept of self-care...

Piramal Pharma Expands Lexington Sterile Injectables Plant

Piramal Pharma has started work on the expansion of...

Christopher Good, Director of Cell and Gene Therapy Logistics at Biocair, will explore ongoing material sourcing challenges for organisations moving from development to clinical and commercial manufacturing in an upcoming webinar taking place on 12 March 2020.

Critical considerations in ensuring patient access to cell and gene therapies, and continued industry growth, include proper understanding of how to manage source material quality and supply chain continuity. The following areas will be covered:

· The importance of defining source material requirements for translation of allogeneic advanced therapies
· The value of a reliable and recallable donor network for consistent source material access
· The critical requirements for obtaining GMP-compliant source materials for commercial manufacture
· Best practice in handling, monitoring and delivering temperature-sensitive source materials
· The importance of early planning, coordination and communication with all stakeholders

Biocair’s industry-leading service offering for cell and gene therapy logistics includes:

• Dedicated project management teams including customer support specialists
• A global network of liquid nitrogen service stations
• 24/7 collection and delivery across the world
• A level of flexibility in service provision unrivalled in the industry

To register for the webinar visit www.biocair.com/events or contact marketing@biocair.com for more information.

About Biocair:

Biocair is a global specialist courier with over 30 years experience in the pharmaceutical, biotechnology and life sciences sectors. The company has built a unique, client-centric approach by employing scientists in front-line logistics positions and assembling a team of best-in-class industry experts in quality, cold chain and regulatory compliance, amongst others. Biocair focuses on providing the most comprehensive service options available, whilst delivering flexible, tailored, cost effective logistics solutions to its clients.

Latest stories

Related stories

Merck to Acquire Verona for $10B, COPD Drug in Focus

Merck has pulled off another acquisition that happens to...

PDUFA Crucial for Biopharmaceutical Innovation in the US

The United States happens to lead the world when...

The Evolution of Self-Care: Where Vitauthority Fits in the Wellness Era

Over the past few decades, the concept of self-care...

Piramal Pharma Expands Lexington Sterile Injectables Plant

Piramal Pharma has started work on the expansion of...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back